Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 4
2017 5
2018 6
2019 7
2020 9
2021 16
2022 22
2023 14
2024 17
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
The multiomics blueprint of the individual with the most extreme lifespan.
Santos-Pujol E, Noguera-Castells A, Casado-Pelaez M, García-Prieto CA, Vasallo C, Campillo-Marcos I, Quero-Dotor C, Crespo-García E, Bueno-Costa A, Setién F, Ferrer G, Davalos V, Mereu E, Pluvinet R, Arribas C, Torre C, Villavicencio F, Sumoy L, Granada I, Coles NS, Acha P, Solé F, Mallo M, Mata C, Peregrina S, Gabaldón T, Llirós M, Pujolassos M, Carreras-Torres R, Lluansí A, García-Gil LJ, Aldeguer X, Samino S, Torné P, Ribalta J, Guardiola M, Amigó N, Yanes O, Martínez P, Sánchez-Vázquez R, Blasco MA, Oviedo J, Lemos B, Rius-Bonet J, Torrubiano M, Massip-Salcedo M, Khidir KA, Cao TH, Quinn PA, Jones DJL, Macip S, Brigos-Barril E, Moldes M, Barteri F, Muntané G, Laayouni H, Navarro A, Esteller M. Santos-Pujol E, et al. Cell Rep Med. 2025 Oct 21;6(10):102368. doi: 10.1016/j.xcrm.2025.102368. Epub 2025 Sep 24. Cell Rep Med. 2025. PMID: 40997805 Free article.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Noureddin M, Truong E, Mayo R, Martínez-Arranz I, Mincholé I, Banales JM, Arrese M, Cusi K, Arias-Loste MT, Bruha R, Romero-Gómez M, Iruzubieta P, Aller R, Ampuero J, Calleja JL, Ibañez-Samaniego L, Aspichueta P, Martín-Duce A, Kushner T, Ortiz P, Harrison SA, Anstee QM, Crespo J, Mato JM, Sanyal AJ. Noureddin M, et al. Hepatology. 2024 Jan 1;79(1):135-148. doi: 10.1097/HEP.0000000000000542. Epub 2023 Jul 24. Hepatology. 2024. PMID: 37505221 Free PMC article.
Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico.
Arrobas Velilla T, Fernández Prendes C, Amigó Grau N, Calmarza P, Camós Anguila S, Candas Estébanez B, Castro Castro MJ, Ceacero D, González Martínez I, Martín Palencia M, Puzo Foncillas J, Romero Román C; en nombre de la Comisión de Lipoproteínas y Enfermedades Cardiovasculares de la SEQCML. Arrobas Velilla T, et al. Adv Lab Med. 2025 Mar 3;6(1):17-27. doi: 10.1515/almed-2024-0090. eCollection 2025 Mar. Adv Lab Med. 2025. PMID: 40160393 Free PMC article. Spanish.
Multiomics in atherosclerotic cardiovascular disease.
Nordestgaard LT, Wolford BN, de Gonzalo-Calvo D, Sopić M, Devaux Y, Matic L, Wettinger SB, Schmid JA, Amigó N, Masana L, Catapano AL, Kardassis D, Magni P; EU-AtheroNET COST Action CA21153. Nordestgaard LT, et al. Atherosclerosis. 2025 Sep;408:120414. doi: 10.1016/j.atherosclerosis.2025.120414. Epub 2025 Jun 26. Atherosclerosis. 2025. PMID: 40663987 Free article. Review.
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma.
Uribe-Herranz M, Oliver-Caldés A, Martínez-Micaelo N, Español-Rego M, Val-Casals M, Martínez-Soler R, Rubio-Garcia E, Brunello V, Mihelic EZ, Klein-González N, Benítez-Ribas D, Amigó N, Vergara A, Ortiz-Maldonado V, Rodríguez-Lobato LG, Delgado J, Ortiz de Landazuri I, González-Calle V, Cabañas V, Martin-Antonio B, Pérez-Amill L, Reguera-Ortega JL, Rodríguez-Otero P, Paiva B, Martínez-López J, Mateos MV, Pascal M, Urbano-Ispizua Á, González-Navarro EA, Fernández de Larrea C, Juan M. Uribe-Herranz M, et al. Blood Cancer Discov. 2025 Sep 3;6(5):484-504. doi: 10.1158/2643-3230.BCD-24-0203. Blood Cancer Discov. 2025. PMID: 40643584
CLN3 deficiency leads to neurological and metabolic perturbations during early development.
Heins-Marroquin U, Singh RR, Perathoner S, Gavotto F, Merino Ruiz C, Patraskaki M, Gomez-Giro G, Kleine Borgmann F, Meyer M, Carpentier A, Warmoes MO, Jäger C, Mittelbronn M, Schwamborn JC, Cordero-Maldonado ML, Crawford AD, Schymanski EL, Linster CL. Heins-Marroquin U, et al. Life Sci Alliance. 2024 Jan 9;7(3):e202302057. doi: 10.26508/lsa.202302057. Print 2024 Mar. Life Sci Alliance. 2024. PMID: 38195117 Free PMC article.
A case of hypocholesterolemia under study.
Camacho A, Ariza MJ, Amigó N, Macías Guillén P, Sánchez Chaparro MÁ, Valdivielso P. Camacho A, et al. Clin Investig Arterioscler. 2023 Sep-Oct;35(5):244-247. doi: 10.1016/j.arteri.2023.05.003. Epub 2023 Jun 9. Clin Investig Arterioscler. 2023. PMID: 37302939 Free article. English, Spanish.
Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study.
Martínez-Falguera D, Aranyó J, Ferrer-Curriu G, Teis A, Revuelta-Lopez E, Diaz-Güemes I, Monguió-Tortajada M, Fadeuilhe E, Rodríguez-Leor O, Poblador F, Montejo B, Roura S, Villuendas R, Sarrias A, Bazan V, Jorge E, Delgado V, Jimenez-Trinidad FR, Rigol M, Martinez-Micaelo N, Amigó N, Bayes-Genis A, Bisbal F, Gálvez-Montón C. Martínez-Falguera D, et al. J Am Heart Assoc. 2025 Jun 3;14(11):e040214. doi: 10.1161/JAHA.124.040214. Epub 2025 May 26. J Am Heart Assoc. 2025. PMID: 40417813 Free PMC article.
106 results